-transparent.png){kind=logo}
The effect of saralasin, a competitive inhibitor of angiotensin II, was assessed in hypertensive patients with unilateral renal artery stenosis after furosemide application. A significant fall of systemic arterial blood pressure, an increase of renal venous renin activity, significantly on the stenosed side in patients without arteriosclerosis of the contralateral kidney, and an almost equal decrement of renal blood flow in both kidneys were observed. Conceivably saralasin exerts different sodium-dependent effects on peripheral angiotensin II and specific intrarenal vascular receptors.
Related Publications
I P Arlart, and
J Rosenthal, and
H Wagner, and
W E Adam, and
F Nobbe, and
H E Franz
January 1977,
Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung,
I P Arlart, and
J Rosenthal, and
H Wagner, and
W E Adam, and
F Nobbe, and
H E Franz
November 1978,
American heart journal,
I P Arlart, and
J Rosenthal, and
H Wagner, and
W E Adam, and
F Nobbe, and
H E Franz
October 1976,
The Journal of urology,
I P Arlart, and
J Rosenthal, and
H Wagner, and
W E Adam, and
F Nobbe, and
H E Franz
September 1978,
Klinische Wochenschrift,
I P Arlart, and
J Rosenthal, and
H Wagner, and
W E Adam, and
F Nobbe, and
H E Franz
January 2010,
British journal of pharmacology,
I P Arlart, and
J Rosenthal, and
H Wagner, and
W E Adam, and
F Nobbe, and
H E Franz
September 1989,
Nursing,
I P Arlart, and
J Rosenthal, and
H Wagner, and
W E Adam, and
F Nobbe, and
H E Franz
January 1983,
Clinical and experimental pharmacology & physiology,
I P Arlart, and
J Rosenthal, and
H Wagner, and
W E Adam, and
F Nobbe, and
H E Franz
August 1977,
Annals of internal medicine,
I P Arlart, and
J Rosenthal, and
H Wagner, and
W E Adam, and
F Nobbe, and
H E Franz
May 1988,
Japanese circulation journal,
I P Arlart, and
J Rosenthal, and
H Wagner, and
W E Adam, and
F Nobbe, and
H E Franz
January 1966,
Surgical forum,
